GLP-1 medicines may have direct kidney and heart benefits Some GLP-1 medicines have been shown in diabetes and obesity populations to improve cardiovascular and kidney outcomes
Oral supplementation has gained popularity for skin brightening, immune support, and cellular repair
SomaScan uses chemically modified nucleotide sequences (aptamers) to transform a protein signal into a nucleotide signal that can be quantified using relative fluorescence on microarrays 8
Look for multiple support channels, knowledgeable agents, and clear escalation paths
Oncoimmunology 7 , e1382790 (2018)
GLP-1 agonists can be a powerful tool to manage diabetes and control weight, but like any medication, theyre not without risks, so talking with your doctor is always a good choice.